Patient-derived xenografts, the cancer stem cell paradigm, and cancer pathobiology in the 21st century
- 1 September 2013
- journal article
- review article
- Published by Elsevier in Laboratory Investigation
- Vol. 93 (9), 970-982
- https://doi.org/10.1038/labinvest.2013.92
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- AACR Cancer Progress Report 2012Clinical Cancer Research, 2012
- Cancer Facts & Figures 2012. American Cancer Society (ACS)Journal of Consumer Health on the Internet, 2012
- Genome sequencing and cancerCurrent Opinion in Genetics & Development, 2012
- Cancer statistics, 2012CA: A Cancer Journal for Clinicians, 2012
- Treatment of Metastatic Colorectal CancerSeminars in Oncology, 2011
- The Tissue Is the Issue: Personalized Medicine for Non-Small Cell Lung CancerClinical Cancer Research, 2010
- Metastatic pancreatic cancer: Is gemcitabine still the best standard treatment? (Review)Oncology Reports, 2010
- Small Cell Lung Cancer: Have We Made Any Progress Over the Last 25 Years?The Oncologist, 2007
- Strategies to eliminate cancer stem cells: Clinical implicationsEuropean Journal Of Cancer, 2006
- The paradox of response and survival in cancer therapeuticsBlood, 2006